In the present study, the serum irisin level of patients in stage 4 was significantly reduced compared with stage 2 patients, this finding is consistent with most studies that suggest that the amount of irisin is decreased in the serum of CKD patients (15, 21). This evidence concerns the gene FNDC5 and chronic kidney disease.